{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:08:51Z","timestamp":1793239731244,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:43:13Z","timestamp":1785717793000},"page":"76-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Baseline neutrophil count, benign ethnic neutropenia risk, and clozapine haematological monitoring: A multi-ethnic retrospective cohort study from the United Arab Emirates"],"prefix":"10.1016","volume":"297","author":[{"given":"Syed Ali","family":"Bokhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhanad","family":"Elnoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal A.","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-8150","authenticated-orcid":false,"given":"Syed Fahad","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.07.026_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis-incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2026.07.026_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.06.003","article-title":"Benign ethnic neutropenia","volume":"37","author":"Atallah-Yunes","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.schres.2026.07.026_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.2024.236","article-title":"Genetic identification of undiagnosed benign ethnic neutropenia in patients receiving clozapine treatment","volume":"227","author":"Aziri","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.07.026_bb0025","series-title":"Clozapine Handbook","author":"Bleakley","year":"2013"},{"key":"10.1016\/j.schres.2026.07.026_bb0030","article-title":"Mask off? Lithium augmentation for clozapine rechallenge after neutropenia or agranulocytosis: discontinuation might be risky","volume":"20","author":"Boazak","year":"2018","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2026.07.026_bb0035","series-title":"Clozapine \u2013 prescribing and monitoring guideline (Version 4.0) (Policy No. Policy No. MM04)","author":"Cambridgeshire and Peterborough NHS Foundation Trust","year":"2023"},{"key":"10.1016\/j.schres.2026.07.026_bb0040","series-title":"FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine","author":"Center for Drug Evaluation and Research","year":"2025"},{"key":"10.1016\/j.schres.2026.07.026_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2326-9-3","article-title":"Prevalence, phenotype and inheritance of benign neutropenia in Arabs","volume":"9","author":"Denic","year":"2009","journal-title":"BMC Hematol."},{"key":"10.1016\/j.schres.2026.07.026_bb0050","series-title":"Clozapine Policy (Version 6.0)","author":"East London NHS Foundation Trust","year":"2021"},{"key":"10.1016\/j.schres.2026.07.026_bb0055","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.schres.2026.07.026_bb0060","article-title":"Global trends in clozapine utilisation between 2014 and 2024: a longitudinal epidemiological study with data from 75 countries","volume":"63","author":"Fitzgerald","year":"2026","journal-title":"Lancet Reg. Health-Eur."},{"key":"10.1016\/j.schres.2026.07.026_bb0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7326\/0003-4819-146-7-200704030-00004","article-title":"Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences","volume":"146","author":"Hsieh","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.schres.2026.07.026_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.schres.2026.07.026_bb0075","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2024014399","article-title":"Characterization of the phenotypic consequences of the Duffy-null genotype","volume":"9","author":"Hysong","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.schres.2026.07.026_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2018.12.011","article-title":"A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulf countries","volume":"39","author":"Ismail","year":"2019","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0085","series-title":"BNF 84 (British National Formulary) September 2022","author":"Joint Formulary Committee","year":"2022"},{"key":"10.1016\/j.schres.2026.07.026_bb0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.schres.2023.08.002","article-title":"Clozapine and neutrophil response in patients of African descent: a six-month, multinational, prospective, open-label clinical trial","volume":"268","author":"Kelly","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.026_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41380-018-0335-7","article-title":"A genome-wide association study in individuals of African ancestry reveals the importance of the Duffy-null genotype in the assessment of clozapine-related neutropenia","volume":"24","author":"Legge","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2026.07.026_bb0110","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.4088\/JCP.15r10085","article-title":"Benign ethnic neutropenia and clozapine use: a systematic review of the evidence and treatment recommendations","volume":"77","author":"Manu","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0115","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00277-020-04215-y","article-title":"Clozapine-induced agranulocytosis","volume":"99","author":"Mijovic","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.schres.2026.07.026_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s44220-025-00554-9","article-title":"ACKR1 genetic testing should be offered before starting clozapine treatment","volume":"4","author":"Murtough","year":"2026","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.schres.2026.07.026_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/bcp.70576","article-title":"ACKR1\/Duffy-null genotype testing for clozapine: a guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)","author":"Murtough","year":"2026","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2026.07.026_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.07.026_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2215-0366(23)00343-7","article-title":"Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study","volume":"11","author":"Northwood","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12888-021-03514-6","article-title":"Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals","volume":"21","author":"Oloyede","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0145","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602200066X","article-title":"Clozapine haematological monitoring for neutropenia: a global perspective","volume":"31","author":"Oloyede","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2026.07.026_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(26)00061-1","article-title":"Clozapine rechallenge after neutropenia: a retrospective cohort study in the UK","volume":"13","author":"Oloyede","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000360","article-title":"Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene","volume":"5","author":"Reich","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.schres.2026.07.026_bb0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S2215-0366(24)00097-X","article-title":"Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case\u2013control study in Finland","volume":"11","author":"Rubio","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2215-0366(25)00001-X","article-title":"Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis","volume":"12","author":"Schneider-Thoma","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0170","article-title":"Late-onset neutropenia in clozapine users: unrelated or drug-induced? A case-registry analysis of incidence, characteristics, and rechallenge attempts","author":"Segev","year":"2025","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.026_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1192\/bjb.2024.38","article-title":"Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it\u2019s a CIN","volume":"49","author":"Silva","year":"2025","journal-title":"BJPsych Bull."},{"key":"10.1016\/j.schres.2026.07.026_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S2215-0366(25)00098-7","article-title":"Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel","volume":"13","author":"Siskind","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0185","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2025"},{"key":"10.1016\/j.schres.2026.07.026_bb0190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng0695-224","article-title":"Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy\u2013negative individuals","volume":"10","author":"Tournamille","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.schres.2026.07.026_bb0195","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.schres.2026.07.026_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2025.10423","article-title":"Evaluation of 96 cases of apparent clozapine-induced severe neutropenia","author":"Wallman","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.026_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/YIC.0000000000000258","article-title":"Need to bleed? Clozapine haematological monitoring approaches a time for change","volume":"34","author":"Whiskey","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.026_bb0210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s44220-025-00411-9","article-title":"The paradox of clozapine in Black people with treatment-resistant schizophrenia","volume":"3","author":"Whiskey","year":"2025","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.schres.2026.07.026_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2023.10.002","article-title":"A brief history and challenges of clozapine utilization in the Arab world","volume":"268","author":"Zolezzi","year":"2024","journal-title":"Schizophr. Res."}],"updated-by":[{"DOI":"10.1016\/j.schres.2026.08.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000}},{"DOI":"10.1016\/j.schres.2026.08.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:04:38Z","timestamp":1791893078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":43,"alternative-id":["S0920996426002379"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.026","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline neutrophil count, benign ethnic neutropenia risk, and clozapine haematological monitoring: A multi-ethnic retrospective cohort study from the United Arab Emirates","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}